On April 28, AEI’s Kirsten Axelsen hosted the former North Carolina Department of Health and Human Services Secretary Kody Kinsley; Anthony DiGiorgio of the University of California, San Francisco; ...
“When a program designed to deliver targeted assistance drives up system-wide costs, reform is no longer optional,” says health expert Sally Pipes. “It's necessary.” If a charity organization ...
9don MSNOpinion
Congress created a drug pricing program to deliver affordability. Instead, it’s raising costs
An autoimmune disease diagnosis can mark the start of a difficult medical battle. But for too many patients, it also marks ...
340B covered entities are expanding contracts with retail pharmacies that are increasingly located in counties with high rates of Medicare and Medicaid insurance coverage. The 340B Drug Pricing ...
Forbes contributors publish independent expert analyses and insights. I am a cable news contributor and professor of journalism. This voice experience is generated by AI. Learn more. This voice ...
Established under the Public Health Service Act in 1992, the 340B drug pricing program has a critical goal: improve access to medicines for low-income patients at qualifying hospitals and clinics.
More than three decades ago, Congress created the 340B program to help safety-net hospitals and clinics expand resources and care for underserved communities. By requiring pharmaceutical companies to ...
The 340B program spent $43.9 billion in 2021, supporting nearly 50,000 hospitals with discounted outpatient drugs. Cancer drugs constitute 41% of 340B purchases, with outpatient departments and ...
Congress needs to act to bring needed reforms into the 340B to make revenue from the drug pricing program more transparent and to ensure patients are benefiting from the discounts, according to a ...
Hospitals in the 340B program will get $9 billion under a proposed rule to make them whole in a lump sum payment, according to the Centers for Medicare and Medicaid Services. An estimated $9 billion ...
Representative Henry A. Waxman, one of the original authors of the 340B drug pricing program, reflects on the changes over the 30 years since its passage. He writes that 340B continues to ensure that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results